Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2026.426 | Investigating Paraspinal Muscle Stiffness Using Shear Wave Elastography (SWE) in Patients with Adolescent Idiopathic Scoliosis (AIS) | Dr. KWAN Cheuk Kin |
| 2023.477 | Primary Diaphyseal Tuberculosis of the Tibia, Presenting as a Pathological Fracture – A Case Report | Dr. KWAN Cheuk Kin |
| 2023.449 | Family caregivers' experience in looking after their relatives dying at home - a qualitative enquiry | Dr. KWAN Cecilia Wai Man |
| 2015.273 | A randomized control trial to evaluate the effectiveness of a short-term life review intervention in enhancing spiritual well-being, quality of life, and lowering anxiety and depression in palliative patients |
Miss KWAN Cecilia Wai Man 關蕙敏 |
| 2024.723 | The effectiveness of an artificial saliva gel in relieving xerostomia in Palliative care patients | Dr. Kwan Cecilia |
| 2007.428 | Efficacy and Safety of Four-Weekly Subcutaneous Darbepoetin for the Maintenance Treatment of Anemia in Peritoneal Dialysis Patients | Dr Kwan Bonnie Ching-Ha |
| 2008.554 | Measurement of adipokines to predict future cardiovascular events in incident peritoneal dialysis patients | Prof Kwan Bonnie Ching Ha |
| 2008.577 | Analysis of the inter-observer variability of Nasoendoscopic Assessment of Nasal Patency | Prof Kwan Bonnie Ching Ha |
| 2009.180 | Prevalence of insulin resistance among incident Chinese peritoneal dialysis patients | Prof. Kwan Bonnie Ching Ha |
| 2009.579 | Cardiovascular Changes in Chronic Kidney Disease: Examining Possible Reversible Factors using Magnetic Reasonable Imaging | Prof. KWAN Bonnie Ching Ha |
| 2009.580 | Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of chronic kidney disease in Hong Kong | Prof. KWAN Bonnie Ching Ha |
| 2012.053 | Management of Hepatitis B in Renal Transplant | Prof Kwan Bonnie Ching Ha |
| 2015.069 | Factors associated with survival of dental implants: A retrospective study of placed implants in a private clinic | Mr. KWAN Andrew Kai Ming |
| 2010.544 | Evluation of Quality of Care - Nurse Allied Health Clinical Programme, HA | Dr. KUNG Kenny |
| 2010.468 | Satisfaction Towards Training: Evaluation of Doctors Working in General Outpatient Clinics | Dr Kung Kenny |
| 2010.542 | Evaluation of Quality of Care - Patient Empowerment Programme, HA | Dr. KUNG Kenny |
| 2010.543 | Evaluation of Quality of Care - Risk Assessment Management Programme, HA | Dr. KUNG Kenny |
| 2010.573 | Patients Attending Hong Kong's General Outpatient Clinics for Upper Respiratory Tract Infection - a retrospective study | Dr Kung Kenny |
| 2011.514 | Upper respiratory tract infection: experience, knowledge and attitude of patients and doctors on medication usage (UREKA) | Dr. KUNG Kenny |
| 2011.114 | Lower Respiratory Tract Infection Pathogens in Hong Kong's Primary Care | Dr. Kung Kenny |
| 2011.113 | Pathogen prevalence and antibiotic resistance among non-surgical chronic wounds in primary care | Dr Kung Kenny |
| 2010.500 | SAVOR Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients with Type 2 Diabetes | Prof Kung Kenny |
| 2013.606 | RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE | Dr. Kung Kenny |
| 2010.501 | SAVOR Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients with Type 2 Diabetes | Prof Kung Kenny |
| 2011.520 | A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Co-Administration of Sitagliptin and Atorvastatin in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Monotherapy | Dr. Kung Kenny |
| 2010.499 | SAVOR Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients with Type 2 Diabetes | Prof Kung Kenny |
| 2011.052 | Evaluation of Quality of Care - Shared-care Programme, HA | Dr. Kung Kenny |
| 2012.215 | Functional characterization of a primate specific microRNA-625 in tumorigenesis | Professor Kung Hsiang-fu |
| 2010.221 | Deciphering the role of makorin-2 in glioblastoma carcinogenesis | Prof Kung Hsiang-fu |
| 2009.213 | Functional characterization of microRNAs associated with glioma carcinogenesis | Prof. Kung Hsiang Fu |
| 2011.014 | p63 regulates cell cycle progression genes and promotes neoplastic stromal cells proliferation in human Giant Cell Tumor of Bone | Prof. Kumta Shekhar Madukhar |
| 2009.011 | Retine acid to promote differentiation of osteoblast-like stromal cells in Giant Cell Tumor of Bone | Prof. Kumta Shekhar Madukhar |
| 2010.098 | Understanding the regulation and mechanistic contributions of the p53 family genes, p53, p63 and p73 in cell proliferation, survival and tumor development in Giant Cell Tumor of Bone | Prof. Kumta Shekhar Madukhar |
| 2007.465 | Peroxisome Proliferator-Activated Receptor Gamma (PPAR gamma) and Retinold X Receptor (RXR) Agonists as Potential Differentiation Therapy Agents for Giants Cell | Professor Kumta Shekhar Madukhar |
| 2013.076 | Characterization of the Giant Cell Tumor of Bone Transcriptome by Next Generation Sequencing | Professor Kumta Shekhar Madhukar |
| 2013.051 | The investigation of potential anti-tumor effects of Denosumab on Giant Cell Tumor of Bone | Professor Kumta Shekhar Madhukar |
| 2011.061 | Treatment of Giant Cell Tumor of Bone by the Combination of Nitrogen-Bisphosponates and Pheny1 Transferase Inhibitors: An in vivo study | Prof. KUMTA Shekhar Madhukar |
| 2019.190 | Investigation of the role of YAP via canonical Hippo and non-Hippo signaling pathways in the pathogenesis in giant cell tumor of bone |
Prof. KUMTA Shekhar Madhukar 古明達 |
| 2015.204 | Elucidation of the functional role of a differentially expressed and alternative splicing variant of filamin B in giant cell tumor of bone |
Prof. KUMTA Shekhar Madhukar 古明達 |
| 2016.430 | Elucidation of Gene Expression Alterations and Somatic Mutations in Giant Cell Tumor of Bone by Next Generation Sequencing |
Prof. KUMTA Shekhar Madhukar 古明達 |
| 2017.229 | Investigation of the Functional Roles of Tissue Factor Signaling on the Pathogenesis of Giant Cell Tumor of Bone |
Prof. KUMTA Shekhar Madhukar 古明達 |
| 2014.305 | Novel insights into Giant Cell Tumor of Bone: Discovery of Differentially Expressed Genes and Tumor-Specific Mutations by Transcriptome Sequencing | Professor Kumta Shekhar Madhukar |
| 2021.746 | Using a special 4 herbs formula for the palliative care of patients suffering from bone secondaries |
Dr. KUMTA Shekhar Madhukar 古明達 |
| 2022.094 | Useful Details for Successful WALANT Techniques for Release of Spastic Upper Limbs | Dr. KUMAR Anubrat |
| 2023.334 | Revisiting the natural history of asymptomatic discoid meniscus | Dr. KUMAR Anubrat |
| 2018.060 | Recurrent Destabilizing Pediatric Pelvic Arterial hemorrhage: Choosing the embolization technique that works | Dr. KUMAR Anubrat |
| 2017.507 | Outcome evaluation of Dynamization through Controlled frame destabilization technique in limb lengthening patients using DXA scan | Dr. KUMAR Anubrat |
| 2017.504 | Gonadal Shields: efficacy in Developmental Dysplasia Of hips (DDH) imaging | Dr. KUMAR Anubrat |
| 2016.112 | Case Control Study of the Association between Diabetic Microvascular Complication and Retinal Vasculature using Retinal Image | Dr. KUANG Lei |
| 2021.097 | Evaluating the relationship between the Hip screening criteria used in the post-neonatal infants to hip dysplasia at walking age and assessment of their efficacy at detecting hip dysplasia | Dr. KUAMR Anubrat |
Page 170 of 289.

